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Biopsy-Proven Amebic Colitis Treated
with Metronidazole
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Maj. Frederick R. Bode, MC, USAF,* and
Capt. Earl J. Van Volkinburg, MC, USAF**
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Amebiasis was diagnosed in a Vietnam veteran and treated in a conventional manner
with diodoquin and tetracycline. Symptoms persisted over the next three and one-half
years despite repeated courses of diodoquin. Amebic colitis was confirmed by biopsy
through a sigmoidoscope. The patient then received a ten-day course of metronidazole
(Flagyl*). Studies are cited proving this single agent is the drug of choice in the oral
therapy of all clinical forms of amebiasis.
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I Amebiasis remains an important conIsideration for the physician faced with the
]Patieni with a diarrheal illness. Recent
review articles'-' have pointed out the
imponance of this (and other) communicable diseases, especially in those returning from Vietnam.
In the late 1960s numerous authors'**
reponed work on a new therapeutic modality, metronidazole (Flagyl®), in treating amebiasis. Since then, the drug has
,l>ecome FADA-approved for this use but
ph^slelan^ remain unaware of this
'nee most clinical data was gathered in
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^'ontreal 101. Quebec. Canada, or to Henry
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^e^ented at the 1972 USA REU R Medical"rgjcal Training Conference. Garmisch. Ger"liny.

163

other countries and from Armed Forces
personnel treated in Vietnam. In reviewing our case of amebiasis, we again draw
attention to this new, simple, and highly effective form of therapy.

Case Report
This 35-year-old white man was first seen at
USAF Hospital. Hahn. Germany, in
December 1971. complaining of tiredness,
eight watery stools per day. and a .S.45-kg (12Ib) weight loss in 19 days. There was no history of "bloody flux ' or fever. While stationed
at Nha Trang AFB. Vietnam, in May 1967. he
had first experienced a diarrheal illness.
.•Mthough this had persisted over the next 11
months accompanied by a weight loss of .18
kgs (40 lbs), he had sought little medical attention until April 1968. Sigmoidoscopy at Grissom .-XFB. Indiana, had revealed multiple ulcerations below 12 cm, barium enema was
negative, but stool specimens revealed the
cysts of entamoeba histolytica. The patient
was treated with tetracycline and diodoquin
and was discharged improved.
Although military public health authorities
examined the entire family, their baby sitter,
close friends, and the water supply of Ihe
trailer park in which the patient lived, no other
cases or evidence of contamination were
found.
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Figure I A.
Sininoid hinps) e\hil)iling a inuiosa! villus wilh a single typical Iropho/oile larrow) in tht larr I
propri:! i lli iii:U<)\\Iiu and eoslii; uriuinal luaguifualion. \I00.)

For the next three years he had noriiiiil
stools when using ili4)doquin and recurrent
diarrhc.i when the medicine was diseonliiuied.
However sUuil specimens were no longer positive for cysts. In March 1971. when a repeat
Mgmoidoseop\ suggested the possibility of
ulcer.ilive colitis, he was hospii;ili/ed ami a
111.1.ll biiips\ was performed. This was nondiagnostic and diodoquin therapy was
resumed In OctoK'r 1971. he was assigned lo
Germany. By late No\ember, he exhausted
his supply of diodoquin. When l.omolil
uliphenow l.ile h\dioehloi idel proved unsue
ccssful in controlling the diarrhea, he reported lo the US.AH hospilal.
There, physical examination revealed no
evidence of jaundice, hepaiomegaly, or
.ilHluminal masses. A number of typical
iNol.iied ulcers were foimd by sigmoidoscopy
Ncatiered throughout the upper rectum and
li>\ver Mgmoid Ihey v.iried from 4 lo 1.^ mm
in diameter .md were round, oval, or buttonhole sh.iped \viih a punehed-out
.ippearancc. Biopsy specimens were taken
from two such lesions (Figures I and 2) fhe
mucos.i in uninvolved segments appeared
noimal. .-N saline prepar.ilion of hi)wel u.ill
>i.i.iping'> showed mobile trophozoites, .i few
.'I hich contained ingested KB( s
On December 17. |97|. the patient began
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taking metronidazole. 750 mg orally, e»f
eight hours for ten days. His diarrhea quiet'
abated: he experienced no side ctTeeis andkt
remained symptom-free since then Whtr':
vvas rehospitalized in .April. 1972. repea'*
warm stage stool examinations were nornul'
sigmoidoscopy show ed no evidence ol the rviously observed abnormalities. Barium enr.uul liver function tests were normal.
examinations of the entire family were
negative.
Discussion
Amebiasis is transmitted only by feci
contamination of water, food, or artii-'
of daily living. The cyst is the only infftive f o r m . .After being ingested, s^"
encasement is digested in the small m'^
tine. By the time it reaches the termirj
i l e u m , the quadranuclear metacy^''
.imeba has been released and then di*"^
into four motile trophozoites. Thesethe forms responsible for clinicalb r
ifested disease." The motile trophoz^^^
continue to pass along with bowel ifi^
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Figure IK
I : ,h-|)in\Lr
lit llie Iropho/oile seen in Figuie l . \ . deinonslraling au ingested red lell. (iiematoxylin
indtMisin: original mugnincalion, X4(I0.)

mens or proctoscopic scrapings.'' Invading trophozoites wilh ingested red hlmnl
cells seen in biopsy specimens are diagnt)stic, as was shown in our case report.
In addition, liver scan and sert)logic tests
are of value in diagnosing extra-intestinal
.imebic disease.'"
In the past, no single drug cured holh
the inleslin.il and extra-intestinal forms of
the disease. Fmetine and chloroquine act
primarily on extra-intestinal disease.
.Arsenicals and hah)gienaled hydroxyqiiinolines act only on the intestinal
phase, as do broad spectrum antibiolics
which alter the bowel f l o r a . " In Ihe
United States, diodoquin has been used
alone for the theiapy ofthe asymptomatic
cyst carrier.'"' While the preferred
therapy for symptomatic amebic dysentery or amebic colitis has been diodoquin
(Vioform) and tetracycline" or emeiinc.
("arbarsone. and Vioform.'-'

bntil they reach favorable conditions for
folonization, usually in the area of the
pecum. Trophozoites either re-encyst to
passed in the stool causing no sympioms and continuing the life cycle, or
|liey can invade the bowel wall. Of the
Monic lesions. 799^ occur in the cecal
Tegion and 29^ in the rectosigmoid area."
Usually only the mucosa and mus'^"laris mucosa are invaded forming (he
f)pical flask-shaped ulcer." However.
"ore rarely, the trophozoites continue
peir invasion through the bowel wall
';susing perforation and peritonitis. Other
•equently seen complications result from
pe trophozoites entering the circulation
I trough portal venules causing amebic
j ^atitis. liver abscess, and more rarely
l^oin or skin abscesses.
Correct diagnosis is best achieved by
' ompt examination of saline wet mount
r-'Parations of freshly passed stool speci16,5
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Figure 2A
Focus of supi'rficial erosiim in Ihe hiopsy spceiman a.s.sociated with necrotic dehris and iniianimalor I Hi
infiltrate. There are numerous large cells containing red cells. (Hematoxylin and eosin; original n)tt| pl
nificalion, XIOO.)

The most significant recent advance in
the treatment of this protozoal infection
is the use of metronidazole. As is true for
all other amebacides except emetine, the
exact mechanism of antiprotazoal activity
is unknown. Metronidazole was first
introduced into clinical medicine in 1959
by Cosar and Julou'^ and in 1960 by
Durel et a/" for the successful treatment
of trichomona! infections in men and
women.
In 1966 Powell and co-workers^ found
encouraging results in the treatment of
.imebiasis with nidazole. a compound
chemiciilly related to melronidazole. but
found the side eflccts were intolerable at
therapeutic dosages. The same year
Powell et al^ conducted clinical trials
with metronidazole in the treatment of
intr;>- and extra-intestinal amebic infeclums. I he results of these first encouraging studies .md others
indicate that

metronidazole is the initial oral drugc
choice in the treatment of all forms o;
amebiasis. Table 1 summarizes the resi.
ofthe best-known studies.
Establishment of optimal dosai:
schedules and assurance that such dose*
would cause no serious side effects ha^;
delayed until recently the acceptance i'metronidazole as the drug of choice ini^
treatment of amebiasis in Nori^
.America.'"
Currently, the pharmaceutical manifacturer recommends for treatmeni ^
acute dysentery in adults 750 mgs oral
three times daily for five to ten days. Thi^
same dosage schedule, which is ah''
recommended for amebic abscess, i'
about three times lhat used for tncti
monal infections in adults. For childrer
35 to 50 mgs per kilogram per 24 hourin three divided daily doses is recom
mended.
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Figure 2B
Hi|>h-povver view of Ihese cells with small pale nuclei containing intracytoplasmic red cells and
pbgiKdIized dehris. This pattern is characlerislic of Entamoeba histolytica. I Hematoxylin and eosin.
bigiiial magnincalion X400.)

Because it is a nitroimidazole. the drug
contraindicated in patients with a hislory of blood dyscrasia. No persistent
hematologic abnormalities have been
observed, but mild reversible neutropenia
My be frequently seen. Alcoholic bever^es should not be consumed by patients
•aking metronidazole because a reaction
similar to that induced by antabuse may
occur. Abnormal cerebellar signs such as
ataxia and dizziness are the third and
final major side effect. If neurological
omplications are observed, the drug

should be discontinued promptly." Minor
gastrointestinal side effects and
headaches have been reported.
Summary
Metronidazole has proven to be safe
and effective in amebiasis. It is presently
the only safe direct-acting amebecide
with activity at all required sites.'" The
reported case illustrates the successful
outcome of such therapy. Other studies
indicate that this single agent is the drug

Table 1. Summary of Pertinent Studies
'uthors
'owell et al, 1966"
.owell et al. 1969^
'*yor 1968'3
'/'nvielle et al, 1969*
^'^on and l^ilier 1970^

Daily Dosage
800 mg tid x 10 days
2.4 gm one dose daily x 2
500-750 mg tid x 10 days
800 mg tid x 10-20 days
250 mg tid x 10-14 days

Number
Patients Success
25
30
13
8
5

22
26
12
8
5

Failure
4
1
0
0
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of choice in oral therapy of all clinical
forms of amebiasis. The treatment is
especially convenient when compared to
the necessary combinations of other
drugs. Significant side effects occur
less frequently.
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